查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1756483

免疫組織化學市場，按產品、應用、最終用戶、國家和地區 - 產業分析、市場規模、市場佔有率及預測（2024 年至 2032 年）

Immunohistochemistry Market, By Offering, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 387 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年免疫組織化學市場規模價值 28.76 億美元，2024 年至 2032 年的複合年成長率為 6.6%。

免疫組織化學市場-市場動態

慢性病盛行率不斷上升

慢性疾病（尤其是癌症）發生率的上升是免疫組織化學市場的主要驅動力。免疫組化 (IHC) 透過檢測組織樣本中的特定生物標記物，在癌症的準確診斷和分類中發揮著至關重要的作用。這有助於制定個人化治療方案，並改善患者的預後。隨著人口老化和生活方式因素導致全球癌症和其他慢性疾病發生率上升，對 IHC 等精準診斷技術的需求也日益成長。此外，IHC 在研究和藥物開發中的應用日益廣泛，透過支持標靶治療和精準醫療的進步，進一步推動了市場的成長。

免疫組織化學市場—關鍵見解

根據我們的研究分析師，全球免疫組織化學市場預計在 2024 年至 2032 年期間的複合年成長率約為 6.6%。

按 2023 年產品細分，抗體類別佔據了市場主導地位。

根據應用，診斷應用部門在 2023 年創造了最多的收入。

按地區分類，2023年北美是收入最高的地區。

免疫組織化學市場-細分分析：

全球免疫組織化學市場分為四大類：產品、應用、最終用戶和地區。

免疫組織化學 (IHC) 市場細分為抗體、試劑、設備、試劑盒和軟體。抗體對於特異性結合組織樣本中的標靶抗原至關重要，使其成為 IHC 過程中的關鍵組成部分。試劑支援染色和可視化的各個階段，而設備包括用於執行和分析測試的顯微鏡、玻片掃描儀和自動染色系統。試劑盒提供即用型抗體和試劑組合，簡化了實驗室的工作流程。軟體解決方案有助於影像分析和資料管理，從而提高準確性和效率。在這些細分市場中，抗體佔據市場主導地位，因為它們在識別生物標記方面發揮著重要作用，對多樣化和高特異性抗體的需求旺盛，並且持續創新，從而推動了全球診斷和研究應用領域的巨大收入和應用。

免疫組織化學 (IHC) 市場按應用分為診斷應用、研究應用和法醫應用。診斷應用是指使用 IHC 技術透過檢測患者組織樣本中的特定生物標記來識別和分類疾病，尤其是癌症。研究應用包括在實驗室和學術環境中使用 IHC 研究疾病機制、藥物開發和生物標記發現。法醫應用在刑事調查中使用 IHC 來識別組織類型和細胞成分。其中，診斷應用佔據了最大的市場佔有率，因為對精準和早期疾病檢測的需求日益成長，尤其是在腫瘤學領域。慢性病盛行率的上升和個人化醫療的日益普及，強烈推動了對臨床診斷中 IHC 的需求，使其成為全球主要的應用領域。

免疫組織化學市場-地理洞察

從地理分佈來看，免疫組織化學市場分佈在北美、亞太地區、拉丁美洲、歐洲、中東和非洲。這些地區根據業務來源國進一步分類。

北美是免疫組織化學市場的主導地區，其驅動力源自於先進的醫療基礎設施、創新診斷技術的廣泛應用以及大量的科研投入。大型製藥和生物技術公司的入駐，加上政府對癌症和慢性病研究的大力投入，共同推動了市場的成長。此外，人們對個人化醫療和早期疾病診斷的認知不斷提高，也推動了免疫組織化學 (IHC) 技術的廣泛應用。美國憑藉對精準診斷工具的強勁需求、完善的報銷政策以及龐大的患者群體，在該地區處於領先地位，這使得北美成為全球免疫組織化學市場的主要收入來源。

歐洲憑藉其發達的醫療保健體係以及日益成長的癌症和其他慢性疾病盛行率，在免疫組織化學市場中佔有重要佔有率。在政府措施和研究資金的支持下，德國、英國和法國等國家在採用先進的免疫組織化學 (IHC) 技術方面處於領先地位。精準醫療日益受到重視，生物製藥研究活動也日益活躍，這進一步推動了免疫組織化學 (IHC) 的需求。歐洲也受益於強大的診斷實驗室和學術機構網路，這促進了免疫組織化學 (IHC) 在臨床診斷和研究中的應用，使其成為全球領先的區域市場。

免疫組織化學市場-競爭格局：

免疫組織化學市場由賽默飛世爾科技、丹納赫集團、羅氏公司和伯樂實驗室等老牌企業主導。這些公司高度重視創新、品質和合規性，提供用於臨床診斷和研究的廣泛抗體、試劑、試劑盒和儀器產品組合。他們投入大量資金進行研發，以提高產品的敏感度和特異性，滿足日益成長的個人化醫療和精準疾病檢測需求。新興公司也透過開發新技術、推動競爭來貢獻力量，從而促進免疫組織化學方法的持續改進，並擴大其在全球醫療保健和研究領域的應用。

最新動態：

2025 年 3 月，賽默飛世爾科技公司推出了全新的自動化 IHC 染色平台，旨在提高臨床實驗室的通量和可重複性。

2024 年 12 月，丹納赫收購了一家領先的數位病理軟體公司，以增強其 IHC 影像分析能力並整合 AI 驅動的診斷。

目錄

第1章：免疫組織化學市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 免疫組織化學市場片段（依產品分類）
    • 免疫組織化學市場片段（按應用）
    • 免疫組織化學市場片段（按最終用戶）
    • 免疫組織化學市場（按國家/地區）
    • 免疫組織化學市場片段（按地區）
  • 競爭洞察

第3章：免疫組織化學主要市場趨勢

  • 免疫組織化學市場促進因素
    • 市場促進因素的影響分析
  • 免疫組織化學市場限制
    • 市場限制的影響分析
  • 免疫組織化學市場機會
  • 免疫組織化學市場未來趨勢

第4章：免疫組織化學產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：免疫組織化學市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • 新冠疫情後影響分析
    • 表現最佳的市場區隔
    • 邊際成長細分市場
    • 最鬆散的細分市場
    • 邊際損失市場區隔

第6章：免疫組織化學市場格局

  • 2023年免疫組織化學市佔分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：免疫組織化學市場－依產品分類

  • 概述
    • 按產品細分市場佔有率分析
    • 抗體
      • 一抗
      • 二抗
      • 單株抗體
      • 多株抗體抗體
    • 試劑
      • 組織學染色
      • 封閉血清和試劑
      • 顯色底物
      • 固定試劑
      • 稀釋劑
      • 有機溶劑
      • 蛋白水解酶
      • 其他試劑
    • 裝置
      • 玻片染色系統
      • 組織處理系統
      • 幻燈片掃描儀
      • 其他設備
    • 套件
      • 人體免疫組織化學試劑盒
      • 動物免疫組織化學試劑盒
    • 軟體

第 8 章：免疫組織化學市場 - 按應用

  • 概述
    • 按應用細分市場佔有率分析
    • 診斷應用
      • 癌症
      • 傳染病
      • 腎臟疾病
      • 自體免疫疾病
      • 神經系統疾病
      • 其他疾病
    • 研究應用
      • 藥物開發與測試
      • 其他研究應用
    • 法醫應用

第9章：免疫組織化學市場－按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 醫院和診斷實驗室
    • 學術研究機構和合約研究組織
    • 其他最終用戶

第 10 章：免疫組織化學市場-按地域分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美免疫組織化學主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（依產品分類）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲免疫組織化學主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模及預測（依產品分類）
    • 歐洲市場規模和預測，按應用
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區免疫組織化學主要製造商
    • 亞太市場規模及預測（按國家/地區）
    • 亞太市場規模及預測（依產品分類）
    • 亞太市場規模及預測（按應用）
    • 亞太市場規模及預測（依最終用戶）
    • 印度
    • 中國
    • 韓國
    • 日本
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲免疫組織化學主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（依產品分類）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲的免疫組織化學主要製造商
    • 中東和非洲市場規模及預測（按國家/地區）
    • 中東和非洲市場規模及預測（依產品分類）
    • 中東和非洲市場規模和預測（按應用）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 11 章：免疫組織化學產業主要供應商分析

  • 競爭儀錶板
  • 公司簡介
    • F. Hoffmann-La Roche Ltd
    • Danaher Corporation
    • Agilent Technologies, Inc
    • Thermo Fisher Scientific Inc.
    • Merck Kgaa
    • Bio-Rad Laboratories, Inc
    • Bio-Techne
    • Becton, Dickinson And Company
    • Takara Bio Inc.
    • Enzo Biochem Inc.
    • Sino Biological, Inc.
    • Sakura Finetek Japan Co., Ltd.
    • Cell Signaling Technology, Inc.
    • Bio Sb
    • Origene Technologies, Inc
    • Eaglebio
    • Biocare Medical, Llc
    • Elabscience Bionovation Inc.
    • Biogenex
    • Diagnostic Biosystems Inc.
    • Histo-Line Laboratories
    • Rockland Immunochemicals, Inc.
    • Candor Bioscience Gmbh
    • Genemed Biotechnologies, Inc.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5291

REPORT HIGHLIGHT

Immunohistochemistry Market size was valued at USD 2,876 Million in 2024, expanding at a CAGR of 6.6% from 2024 to 2032.

The Immunohistochemistry (IHC) market refers to the industry focused on the production and sale of reagents, antibodies, detection kits, instruments, and related services used for IHC techniques. Immunohistochemistry is a laboratory method that uses antibodies to detect specific antigens in tissue samples, aiding in disease diagnosis, especially cancer, and research. The market encompasses products used in hospitals, diagnostic labs, research institutes, and pharmaceutical companies. Growth in this market is driven by rising prevalence of chronic diseases, technological advancements, and increasing demand for personalized medicine and accurate diagnostic tools globally.

Immunohistochemistry Market- Market Dynamics

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases, especially cancer, is a major driver of the immunohistochemistry market. IHC plays a crucial role in accurately diagnosing and classifying cancers by detecting specific biomarkers in tissue samples. This enables personalized treatment plans and better patient outcomes. As global cancer rates and other chronic illnesses grow due to aging populations and lifestyle factors, the demand for precise diagnostic techniques like IHC increases. Additionally, the expanding use of IHC in research and drug development further propels market growth by supporting advancements in targeted therapies and precision medicine.

Immunohistochemistry Market- Key Insights

According to our research analyst, the global Immunohistochemistry Market is expected to develop at a CAGR of approximately 6.6% between 2024-2032.

Segmented by Offerings in 2023, the Antibodies category dominated the market.

Based on Application, the Diagnostic Applications segment generated the most income in 2023.

On the basis of region, in 2023, North America was the region with the highest revenue.

Immunohistochemistry Market- Segmentation Analysis:

The global Immunohistochemistry Market is divided into Four categories: Offering, Application, End User, and Region.

The Immunohistochemistry (IHC) market is segmented by offering into Antibodies, Reagents, Equipment, Kits, and Software. Antibodies are essential for specifically binding to target antigens in tissue samples, making them a critical component in IHC processes. Reagents support various stages of staining and visualization, while Equipment includes microscopes, slide scanners, and automated staining systems used to perform and analyze tests. Kits provide ready-to-use combinations of antibodies and reagents, simplifying workflows for laboratories. Software solutions aid in image analysis and data management, enhancing accuracy and efficiency. Among these segments, Antibodies dominate the market due to their fundamental role in identifying biomarkers, high demand for diverse and highly specific antibodies, and continuous innovations, which drive significant revenue and adoption across diagnostic and research applications worldwide.

The Immunohistochemistry (IHC) market is categorized by application into Diagnostic Applications, Research Applications, and Forensic Applications. Diagnostic applications represent the use of IHC techniques to identify and classify diseases, particularly cancers, by detecting specific biomarkers in patient tissue samples. Research applications involve studying disease mechanisms, drug development, and biomarker discovery using IHC in laboratories and academic settings. Forensic applications use IHC for identifying tissue types and cellular components in criminal investigations. Among these, Diagnostic Applications hold the largest share of the market due to the growing need for precise and early disease detection, especially in oncology. The rising prevalence of chronic diseases and increasing adoption of personalized medicine strongly drive the demand for IHC in clinical diagnostics, making it the dominant application segment globally.

Immunohistochemistry Market- Geographical Insights

Geographically, the Immunohistochemistry Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the Immunohistochemistry market, driven by advanced healthcare infrastructure, high adoption of innovative diagnostic technologies, and significant research investments. The presence of major pharmaceutical and biotechnology companies, coupled with strong government funding for cancer and chronic disease research, fuels market growth. Additionally, increasing awareness about personalized medicine and early disease diagnosis supports widespread use of IHC techniques. The U.S. leads the region with robust demand for precise diagnostic tools, well-established reimbursement policies, and a large patient pool, making North America a key revenue contributor in the global immunohistochemistry market.

Europe holds a significant share in the Immunohistochemistry market due to its well-developed healthcare systems and increasing prevalence of cancer and other chronic diseases. Countries like Germany, the UK, and France are at the forefront of adopting advanced IHC technologies, supported by government initiatives and research funding. The rising focus on precision medicine and expanding biopharmaceutical research activities further drive demand. Europe also benefits from a strong network of diagnostic laboratories and academic institutions, promoting the use of IHC for both clinical diagnostics and research purposes, positioning it as a dominant regional market globally.

Immunohistochemistry Market- Competitive Landscape:

The Immunohistochemistry market is dominated by established players like Thermo Fisher Scientific, Danaher Corporation, F. Hoffmann-La Roche Ltd, and Bio-Rad Laboratories. These companies focus heavily on innovation, quality, and regulatory compliance, offering a broad portfolio of antibodies, reagents, kits, and instruments for clinical diagnostics and research. They invest substantially in R&D to enhance product sensitivity and specificity, catering to the growing demand for personalized medicine and accurate disease detection. Emerging companies also contribute by developing novel technologies, driving competition that fosters continuous improvement in IHC methodologies and expands adoption in healthcare and research sectors worldwide.

Recent Developments:

In March 2025, Thermo Fisher Scientific Inc. launched a new automated IHC staining platform designed to improve throughput and reproducibility in clinical laboratories.

In December 2024, Danaher Corporation acquired a leading digital pathology software firm to enhance its IHC image analysis capabilities and integrate AI-driven diagnostics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOHISTOCHEMISTRY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • Agilent Technologies, Inc
  • Thermo Fisher Scientific Inc.
  • Merck Kgaa
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • Becton, Dickinson And Company
  • Takara Bio Inc.
  • Enzo Biochem Inc.
  • Sino Biological, Inc.
  • Sakura Finetek Japan Co., Ltd.
  • Cell Signaling Technology, Inc.
  • Bio Sb
  • Origene Technologies, Inc
  • Eaglebio
  • Biocare Medical, Llc
  • Elabscience Bionovation Inc.
  • Biogenex
  • Diagnostic Biosystems Inc.
  • Histo-Line Laboratories
  • Rockland Immunochemicals, Inc.
  • Candor Bioscience Gmbh
  • Genemed Biotechnologies, Inc.
  • Others

GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING - MARKET ANALYSIS, 2019 - 2032

  • Antibodies
  • Primary Antibodies
  • Secondary Antibodies
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Reagents
  • Histological Stains
  • Blocking Sera And Reagents
  • Chromogenic Substrates
  • Fixation Reagents
  • Diluents
  • Organic Solvents
  • Proteolytic Enzymes
  • Other Reagents
  • Equipment
  • Slide-Staining Systems
  • Tissue Processing Systems
  • Slide Scanners
  • Other Equipment
  • Kits
  • Human Immunohistochemistry Kits
  • Animal Immunohistochemistry Kits
  • Software

GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Diagnostic Applications
  • Cancer
  • Infectious Diseases
  • Nephrological Diseases
  • Autoimmune Diseases
  • Neurological Diseases
  • Other Diseases
  • Research Applications
  • Drug Development And Testing
  • Other Research Applications
  • Forensic Applications

GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Hospitals And Diagnostic Laboratories
  • Academic & Research Institutes And Contract Research Organizations
  • Other End Users

GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Immunohistochemistry Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Immunohistochemistry Market Snippet by Offerings
    • 2.1.2. Immunohistochemistry Market Snippet by Application
    • 2.1.3. Immunohistochemistry Market Snippet by End User
    • 2.1.4. Immunohistochemistry Market Snippet by Country
    • 2.1.5. Immunohistochemistry Market Snippet by Region
  • 2.2. Competitive Insights

3. Immunohistochemistry Key Market Trends

  • 3.1. Immunohistochemistry Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Immunohistochemistry Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Immunohistochemistry Market Opportunities
  • 3.4. Immunohistochemistry Market Future Trends

4. Immunohistochemistry Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Immunohistochemistry Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Immunohistochemistry Market Landscape

  • 6.1. Immunohistochemistry Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Immunohistochemistry Market - By Offerings

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Offerings, 2023 & 2032 (%)
    • 7.1.2. Antibodies
      • 7.1.2.1. Primary Antibodies
      • 7.1.2.2. Secondary Antibodies
      • 7.1.2.3. Monoclonal Antibodies
      • 7.1.2.4. Polyclonal Antibodies
    • 7.1.3. Reagents
      • 7.1.3.1. Histological Stains
      • 7.1.3.2. Blocking Sera And Reagents
      • 7.1.3.3. Chromogenic Substrates
      • 7.1.3.4. Fixation Reagents
      • 7.1.3.5. Diluents
      • 7.1.3.6. Organic Solvents
      • 7.1.3.7. Proteolytic Enzymes
      • 7.1.3.8. Other Reagents
    • 7.1.4. Equipment
      • 7.1.4.1. Slide-Staining Systems
      • 7.1.4.2. Tissue Processing Systems
      • 7.1.4.3. Slide Scanners
      • 7.1.4.4. Other Equipment
    • 7.1.5. Kits
      • 7.1.5.1. Human Immunohistochemistry Kits
      • 7.1.5.2. Animal Immunohistochemistry Kits
    • 7.1.6. Software

8. Immunohistochemistry Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Diagnostic Applications
      • 8.1.2.1. Cancer
      • 8.1.2.2. Infectious Diseases
      • 8.1.2.3. Nephrological Diseases
      • 8.1.2.4. Autoimmune Diseases
      • 8.1.2.5. Neurological Diseases
      • 8.1.2.6. Other Diseases
    • 8.1.3. Research Applications
      • 8.1.3.1. Drug Development and Testing
      • 8.1.3.2. Other Research Applications
    • 8.1.4. Forensic Applications

9. Immunohistochemistry Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals And Diagnostic Laboratories
    • 9.1.3. Academic & Research Institutes and Contract Research Organizations
    • 9.1.4. Other End Users

10. Immunohistochemistry Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Immunohistochemistry Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Immunohistochemistry Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Immunohistochemistry Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Immunohistochemistry Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Immunohistochemistry Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Immunohistochemistry Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. F. Hoffmann-La Roche Ltd
    • 11.2.2. Danaher Corporation
    • 11.2.3. Agilent Technologies, Inc
    • 11.2.4. Thermo Fisher Scientific Inc.
    • 11.2.5. Merck Kgaa
    • 11.2.6. Bio-Rad Laboratories, Inc
    • 11.2.7. Bio-Techne
    • 11.2.8. Becton, Dickinson And Company
    • 11.2.9. Takara Bio Inc.
    • 11.2.10. Enzo Biochem Inc.
    • 11.2.11. Sino Biological, Inc.
    • 11.2.12. Sakura Finetek Japan Co., Ltd.
    • 11.2.13. Cell Signaling Technology, Inc.
    • 11.2.14. Bio Sb
    • 11.2.15. Origene Technologies, Inc
    • 11.2.16. Eaglebio
    • 11.2.17. Biocare Medical, Llc
    • 11.2.18. Elabscience Bionovation Inc.
    • 11.2.19. Biogenex
    • 11.2.20. Diagnostic Biosystems Inc.
    • 11.2.21. Histo-Line Laboratories
    • 11.2.22. Rockland Immunochemicals, Inc.
    • 11.2.23. Candor Bioscience Gmbh
    • 11.2.24. Genemed Biotechnologies, Inc.
    • 11.2.25. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us